Article info
PDFElectronic pages
Correspondence
Infliximab and CT-P13 immunogenicity assessment in PLANETAS and PLANETRAS main and extension studies: utility of laboratory methods description
- Correspondence to Dr Francesca Meacci, Immunology and Allergology Laboratory, San Giovanni di Dio Hospital, via di Torre Galli 1, Firenze 50143, Italy; francesca.meacci{at}uslcentro.toscana.it
Citation
Infliximab and CT-P13 immunogenicity assessment in PLANETAS and PLANETRAS main and extension studies: utility of laboratory methods description
Publication history
- Received June 18, 2016
- Accepted June 20, 2016
- First published July 11, 2016.
Online issue publication
September 24, 2016
Article Versions
- Previous version (9 September 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/